{"nct_id":"NCT00866658","title":"GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin +/- Sulfonylurea (GETGOAL-L-ASIA)","status":"COMPLETED","status_verified_date":"2016-08","start_date":"2009-03","start_date_type":null,"primary_completion_date":"2010-06","primary_completion_date_type":"ACTUAL","completion_date":"2010-06","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["SNY"]}